Literature DB >> 2695839

Localization and characterization of dystrophin in muscle biopsy specimens from Duchenne muscular dystrophy and various neuromuscular disorders.

M Uchino1, S Araki, T Miike, H Teramoto, T Nakamura, T Yasutake.   

Abstract

Dystrophin, surmised to be the causative protein of Duchenne muscular dystrophy (DMD), was studied for its intracellular localization and characterization by immunostaining and Western blotting using antidystrophin antibodies. In normal controls and in patients with various neuromuscular diseases other than DMD and Becker's muscular dystrophy (BMD), dystrophin was detected homogeneously on the entire surface membrane of the muscle fibers, whereas it was absent in DMD patients and partially observed in BMD cases. The density of dystrophin was low in BMD and female DMD patients. In mouse skeletal and cardiac muscles, too, dystrophin localized in the muscle surface membrane, and its presence in the brain was also suggested. However, dystrophin was not detected in mdx mice. These data suggest that myofiber necrosis in DMD patients and mdx mice is likely to be the result of plasma membrane instability.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2695839     DOI: 10.1002/mus.880121209

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  7 in total

1.  Size and localization of dystrophin molecule: immunoelectron microscopic and freeze etching studies of muscle plasma membranes of murine skeletal myofibers.

Authors:  Y Wakayama; S Shibuya; T Jimi; A Takeda; H Oniki
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

2.  Dystrophin and dystrophin-related protein in the central nervous system of normal controls and Duchenne muscular dystrophy.

Authors:  M Uchino; H Teramoto; H Naoe; T Miike; K Yoshioka; M Ando
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

3.  Localisation and characterisation of dystrophin in the central nervous system of controls and patients with Duchenne muscular dystrophy.

Authors:  M Uchino; H Teramoto; H Naoe; K Yoshioka; T Miike; M Ando
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-04       Impact factor: 10.154

4.  Lung and respiratory muscle function in limb girdle muscular dystrophy.

Authors:  J P Stübgen; G J Ras; C M Schultz; G Crowther
Journal:  Thorax       Date:  1994-01       Impact factor: 9.139

5.  Congenital muscular dystrophy. A study on the variability of morphological changes and dystrophin distribution in muscle biopsies.

Authors:  Q H Leyten; H J ter Laak; F J Gabreëls; W O Renier; K Renkawek; R C Sengers
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

6.  Cell-lineage regulated myogenesis for dystrophin replacement: a novel therapeutic approach for treatment of muscular dystrophy.

Authors:  En Kimura; Jay J Han; Sheng Li; Brent Fall; Jennifer Ra; Miki Haraguchi; Stephen J Tapscott; Jeffrey S Chamberlain
Journal:  Hum Mol Genet       Date:  2008-05-29       Impact factor: 6.150

7.  Becker muscular dystrophy-like myopathy regarded as so-called "fatty muscular dystrophy" in a pig: a case report and its diagnostic method.

Authors:  Noriyuki Horiuchi; Naoyuki Aihara; Hiroshi Mizutani; Shinichi Kousaka; Tsuneyuki Nagafuchi; Mariko Ochiai; Kazuhiko Ochiai; Yoshiyasu Kobayashi; Hidefumi Furuoka; Tetsuo Asai; Koji Oishi
Journal:  J Vet Med Sci       Date:  2013-10-28       Impact factor: 1.267

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.